Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$36.54 - $48.66 $252,089 - $335,705
6,899 New
6,899 $305,000
Q1 2022

May 16, 2022

SELL
$29.88 - $37.04 $528,009 - $654,533
-17,671 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$25.61 - $35.1 $452,554 - $620,252
17,671 New
17,671 $538,000
Q3 2019

Nov 08, 2019

SELL
$59.06 - $72.15 $240,610 - $293,939
-4,074 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$62.09 - $86.14 $252,954 - $350,934
4,074 New
4,074 $262,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.02B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.